Report cover image

Global Oral Retinoids Industry Growth and Trends Forecast to 2031

Publisher APO Research, Inc.
Published Jul 07, 2025
Length 127 Pages
SKU # APRC20339754

Description

Summary

According to APO Research, The global Oral Retinoids market was estimated at US$ million in 2025 and is projected to reach a revised size of US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2026-2031.

North American market for Oral Retinoids is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Asia-Pacific market for Oral Retinoids is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Europe market for Oral Retinoids is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

The major global manufacturers of Oral Retinoids include Chongqing Huapont Pharmaceutical, Sichuan Med-Shine Pharmaceutical, Shandong Liangfu Pharmaceutical, Heilongjiang Fuhe Pharmaceutical, Harbin Dazhong Pharmaceutical, HEC Pharm, Zydus, Upsher-Smith and Teva, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Oral Retinoids, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oral Retinoids.
The Oral Retinoids market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Oral Retinoids market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.

Oral Retinoids Segment by Company

Chongqing Huapont Pharmaceutical
Sichuan Med-Shine Pharmaceutical
Shandong Liangfu Pharmaceutical
Heilongjiang Fuhe Pharmaceutical
Harbin Dazhong Pharmaceutical
HEC Pharm
Zydus
Upsher-Smith
Teva
Stiefel Laboratories
Sigmapharm Laboratories
Par Pharmaceutical
Mylan
Impax Laboratories
GlaxoSmithKline
Galderma Laboratories
Fuji Pharma
Dr. Reddy's Laboratories
Bausch Health
Barr Pharmaceuticals
Amneal Pharmaceuticals
Alembic
Actavis
Oral Retinoids Segment by Type

Alitretinoin
Acitretin
Bexarotene
Tretinoin
Isotretinoin
Oral Retinoids Segment by Application

Hospital and Clinic
Pharmacy
Other
Oral Retinoids Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oral Retinoids market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Oral Retinoids and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oral Retinoids.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Oral Retinoids manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Oral Retinoids in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

127 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Oral Retinoids Market Size Estimates and Forecasts (2020-2031)
1.2.2 Global Oral Retinoids Sales Estimates and Forecasts (2020-2031)
1.3 Oral Retinoids Market by Type
1.3.1 Alitretinoin
1.3.2 Acitretin
1.3.3 Bexarotene
1.3.4 Tretinoin
1.3.5 Isotretinoin
1.4 Global Oral Retinoids Market Size by Type
1.4.1 Global Oral Retinoids Market Size Overview by Type (2020-2031)
1.4.2 Global Oral Retinoids Historic Market Size Review by Type (2020-2025)
1.4.3 Global Oral Retinoids Forecasted Market Size by Type (2026-2031)
1.5 Key Regions Market Size by Type
1.5.1 North America Oral Retinoids Sales Breakdown by Type (2020-2025)
1.5.2 Europe Oral Retinoids Sales Breakdown by Type (2020-2025)
1.5.3 Asia-Pacific Oral Retinoids Sales Breakdown by Type (2020-2025)
1.5.4 South America Oral Retinoids Sales Breakdown by Type (2020-2025)
1.5.5 Middle East and Africa Oral Retinoids Sales Breakdown by Type (2020-2025)
2 Global Market Dynamics
2.1 Oral Retinoids Industry Trends
2.2 Oral Retinoids Industry Drivers
2.3 Oral Retinoids Industry Opportunities and Challenges
2.4 Oral Retinoids Industry Restraints
3 Market Competitive Landscape by Company
3.1 Global Top Players by Oral Retinoids Revenue (2020-2025)
3.2 Global Top Players by Oral Retinoids Sales (2020-2025)
3.3 Global Top Players by Oral Retinoids Price (2020-2025)
3.4 Global Oral Retinoids Industry Company Ranking, 2023 VS 2024 VS 2025
3.5 Global Oral Retinoids Major Company Production Sites & Headquarters
3.6 Global Oral Retinoids Company, Product Type & Application
3.7 Global Oral Retinoids Company Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global Oral Retinoids Market CR5 and HHI
3.8.2 Global Top 5 and 10 Oral Retinoids Players Market Share by Revenue in 2024
3.8.3 2023 Oral Retinoids Tier 1, Tier 2, and Tier 3
4 Oral Retinoids Regional Status and Outlook
4.1 Global Oral Retinoids Market Size and CAGR by Region: 2020 VS 2024 VS 2031
4.2 Global Oral Retinoids Historic Market Size by Region
4.2.1 Global Oral Retinoids Sales in Volume by Region (2020-2025)
4.2.2 Global Oral Retinoids Sales in Value by Region (2020-2025)
4.2.3 Global Oral Retinoids Sales (Volume & Value), Price and Gross Margin (2020-2025)
4.3 Global Oral Retinoids Forecasted Market Size by Region
4.3.1 Global Oral Retinoids Sales in Volume by Region (2026-2031)
4.3.2 Global Oral Retinoids Sales in Value by Region (2026-2031)
4.3.3 Global Oral Retinoids Sales (Volume & Value), Price and Gross Margin (2026-2031)
5 Oral Retinoids by Application
5.1 Oral Retinoids Market by Application
5.1.1 Hospital and Clinic
5.1.2 Pharmacy
5.1.3 Other
5.2 Global Oral Retinoids Market Size by Application
5.2.1 Global Oral Retinoids Market Size Overview by Application (2020-2031)
5.2.2 Global Oral Retinoids Historic Market Size Review by Application (2020-2025)
5.2.3 Global Oral Retinoids Forecasted Market Size by Application (2026-2031)
5.3 Key Regions Market Size by Application
5.3.1 North America Oral Retinoids Sales Breakdown by Application (2020-2025)
5.3.2 Europe Oral Retinoids Sales Breakdown by Application (2020-2025)
5.3.3 Asia-Pacific Oral Retinoids Sales Breakdown by Application (2020-2025)
5.3.4 South America Oral Retinoids Sales Breakdown by Application (2020-2025)
5.3.5 Middle East and Africa Oral Retinoids Sales Breakdown by Application (2020-2025)
6 Company Profiles
6.1 Chongqing Huapont Pharmaceutical
6.1.1 Chongqing Huapont Pharmaceutical Comapny Information
6.1.2 Chongqing Huapont Pharmaceutical Business Overview
6.1.3 Chongqing Huapont Pharmaceutical Oral Retinoids Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Chongqing Huapont Pharmaceutical Oral Retinoids Product Portfolio
6.1.5 Chongqing Huapont Pharmaceutical Recent Developments
6.2 Sichuan Med-Shine Pharmaceutical
6.2.1 Sichuan Med-Shine Pharmaceutical Comapny Information
6.2.2 Sichuan Med-Shine Pharmaceutical Business Overview
6.2.3 Sichuan Med-Shine Pharmaceutical Oral Retinoids Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Sichuan Med-Shine Pharmaceutical Oral Retinoids Product Portfolio
6.2.5 Sichuan Med-Shine Pharmaceutical Recent Developments
6.3 Shandong Liangfu Pharmaceutical
6.3.1 Shandong Liangfu Pharmaceutical Comapny Information
6.3.2 Shandong Liangfu Pharmaceutical Business Overview
6.3.3 Shandong Liangfu Pharmaceutical Oral Retinoids Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Shandong Liangfu Pharmaceutical Oral Retinoids Product Portfolio
6.3.5 Shandong Liangfu Pharmaceutical Recent Developments
6.4 Heilongjiang Fuhe Pharmaceutical
6.4.1 Heilongjiang Fuhe Pharmaceutical Comapny Information
6.4.2 Heilongjiang Fuhe Pharmaceutical Business Overview
6.4.3 Heilongjiang Fuhe Pharmaceutical Oral Retinoids Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Heilongjiang Fuhe Pharmaceutical Oral Retinoids Product Portfolio
6.4.5 Heilongjiang Fuhe Pharmaceutical Recent Developments
6.5 Harbin Dazhong Pharmaceutical
6.5.1 Harbin Dazhong Pharmaceutical Comapny Information
6.5.2 Harbin Dazhong Pharmaceutical Business Overview
6.5.3 Harbin Dazhong Pharmaceutical Oral Retinoids Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Harbin Dazhong Pharmaceutical Oral Retinoids Product Portfolio
6.5.5 Harbin Dazhong Pharmaceutical Recent Developments
6.6 HEC Pharm
6.6.1 HEC Pharm Comapny Information
6.6.2 HEC Pharm Business Overview
6.6.3 HEC Pharm Oral Retinoids Sales, Revenue and Gross Margin (2020-2025)
6.6.4 HEC Pharm Oral Retinoids Product Portfolio
6.6.5 HEC Pharm Recent Developments
6.7 Zydus
6.7.1 Zydus Comapny Information
6.7.2 Zydus Business Overview
6.7.3 Zydus Oral Retinoids Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Zydus Oral Retinoids Product Portfolio
6.7.5 Zydus Recent Developments
6.8 Upsher-Smith
6.8.1 Upsher-Smith Comapny Information
6.8.2 Upsher-Smith Business Overview
6.8.3 Upsher-Smith Oral Retinoids Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Upsher-Smith Oral Retinoids Product Portfolio
6.8.5 Upsher-Smith Recent Developments
6.9 Teva
6.9.1 Teva Comapny Information
6.9.2 Teva Business Overview
6.9.3 Teva Oral Retinoids Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Teva Oral Retinoids Product Portfolio
6.9.5 Teva Recent Developments
6.10 Stiefel Laboratories
6.10.1 Stiefel Laboratories Comapny Information
6.10.2 Stiefel Laboratories Business Overview
6.10.3 Stiefel Laboratories Oral Retinoids Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Stiefel Laboratories Oral Retinoids Product Portfolio
6.10.5 Stiefel Laboratories Recent Developments
6.11 Sigmapharm Laboratories
6.11.1 Sigmapharm Laboratories Comapny Information
6.11.2 Sigmapharm Laboratories Business Overview
6.11.3 Sigmapharm Laboratories Oral Retinoids Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Sigmapharm Laboratories Oral Retinoids Product Portfolio
6.11.5 Sigmapharm Laboratories Recent Developments
6.12 Par Pharmaceutical
6.12.1 Par Pharmaceutical Comapny Information
6.12.2 Par Pharmaceutical Business Overview
6.12.3 Par Pharmaceutical Oral Retinoids Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Par Pharmaceutical Oral Retinoids Product Portfolio
6.12.5 Par Pharmaceutical Recent Developments
6.13 Mylan
6.13.1 Mylan Comapny Information
6.13.2 Mylan Business Overview
6.13.3 Mylan Oral Retinoids Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Mylan Oral Retinoids Product Portfolio
6.13.5 Mylan Recent Developments
6.14 Impax Laboratories
6.14.1 Impax Laboratories Comapny Information
6.14.2 Impax Laboratories Business Overview
6.14.3 Impax Laboratories Oral Retinoids Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Impax Laboratories Oral Retinoids Product Portfolio
6.14.5 Impax Laboratories Recent Developments
6.15 GlaxoSmithKline
6.15.1 GlaxoSmithKline Comapny Information
6.15.2 GlaxoSmithKline Business Overview
6.15.3 GlaxoSmithKline Oral Retinoids Sales, Revenue and Gross Margin (2020-2025)
6.15.4 GlaxoSmithKline Oral Retinoids Product Portfolio
6.15.5 GlaxoSmithKline Recent Developments
6.16 Galderma Laboratories
6.16.1 Galderma Laboratories Comapny Information
6.16.2 Galderma Laboratories Business Overview
6.16.3 Galderma Laboratories Oral Retinoids Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Galderma Laboratories Oral Retinoids Product Portfolio
6.16.5 Galderma Laboratories Recent Developments
6.17 Fuji Pharma
6.17.1 Fuji Pharma Comapny Information
6.17.2 Fuji Pharma Business Overview
6.17.3 Fuji Pharma Oral Retinoids Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Fuji Pharma Oral Retinoids Product Portfolio
6.17.5 Fuji Pharma Recent Developments
6.18 Dr. Reddy's Laboratories
6.18.1 Dr. Reddy's Laboratories Comapny Information
6.18.2 Dr. Reddy's Laboratories Business Overview
6.18.3 Dr. Reddy's Laboratories Oral Retinoids Sales, Revenue and Gross Margin (2020-2025)
6.18.4 Dr. Reddy's Laboratories Oral Retinoids Product Portfolio
6.18.5 Dr. Reddy's Laboratories Recent Developments
6.19 Bausch Health
6.19.1 Bausch Health Comapny Information
6.19.2 Bausch Health Business Overview
6.19.3 Bausch Health Oral Retinoids Sales, Revenue and Gross Margin (2020-2025)
6.19.4 Bausch Health Oral Retinoids Product Portfolio
6.19.5 Bausch Health Recent Developments
6.20 Barr Pharmaceuticals
6.20.1 Barr Pharmaceuticals Comapny Information
6.20.2 Barr Pharmaceuticals Business Overview
6.20.3 Barr Pharmaceuticals Oral Retinoids Sales, Revenue and Gross Margin (2020-2025)
6.20.4 Barr Pharmaceuticals Oral Retinoids Product Portfolio
6.20.5 Barr Pharmaceuticals Recent Developments
6.21 Amneal Pharmaceuticals
6.21.1 Amneal Pharmaceuticals Comapny Information
6.21.2 Amneal Pharmaceuticals Business Overview
6.21.3 Amneal Pharmaceuticals Oral Retinoids Sales, Revenue and Gross Margin (2020-2025)
6.21.4 Amneal Pharmaceuticals Oral Retinoids Product Portfolio
6.21.5 Amneal Pharmaceuticals Recent Developments
6.22 Alembic
6.22.1 Alembic Comapny Information
6.22.2 Alembic Business Overview
6.22.3 Alembic Oral Retinoids Sales, Revenue and Gross Margin (2020-2025)
6.22.4 Alembic Oral Retinoids Product Portfolio
6.22.5 Alembic Recent Developments
6.23 Actavis
6.23.1 Actavis Comapny Information
6.23.2 Actavis Business Overview
6.23.3 Actavis Oral Retinoids Sales, Revenue and Gross Margin (2020-2025)
6.23.4 Actavis Oral Retinoids Product Portfolio
6.23.5 Actavis Recent Developments
7 North America by Country
7.1 North America Oral Retinoids Sales by Country
7.1.1 North America Oral Retinoids Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
7.1.2 North America Oral Retinoids Sales by Country (2020-2025)
7.1.3 North America Oral Retinoids Sales Forecast by Country (2026-2031)
7.2 North America Oral Retinoids Market Size by Country
7.2.1 North America Oral Retinoids Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
7.2.2 North America Oral Retinoids Market Size by Country (2020-2025)
7.2.3 North America Oral Retinoids Market Size Forecast by Country (2026-2031)
8 Europe by Country
8.1 Europe Oral Retinoids Sales by Country
8.1.1 Europe Oral Retinoids Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
8.1.2 Europe Oral Retinoids Sales by Country (2020-2025)
8.1.3 Europe Oral Retinoids Sales Forecast by Country (2026-2031)
8.2 Europe Oral Retinoids Market Size by Country
8.2.1 Europe Oral Retinoids Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
8.2.2 Europe Oral Retinoids Market Size by Country (2020-2025)
8.2.3 Europe Oral Retinoids Market Size Forecast by Country (2026-2031)
9 Asia-Pacific by Country
9.1 Asia-Pacific Oral Retinoids Sales by Country
9.1.1 Asia-Pacific Oral Retinoids Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
9.1.2 Asia-Pacific Oral Retinoids Sales by Country (2020-2025)
9.1.3 Asia-Pacific Oral Retinoids Sales Forecast by Country (2026-2031)
9.2 Asia-Pacific Oral Retinoids Market Size by Country
9.2.1 Asia-Pacific Oral Retinoids Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
9.2.2 Asia-Pacific Oral Retinoids Market Size by Country (2020-2025)
9.2.3 Asia-Pacific Oral Retinoids Market Size Forecast by Country (2026-2031)
10 South America by Country
10.1 South America Oral Retinoids Sales by Country
10.1.1 South America Oral Retinoids Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
10.1.2 South America Oral Retinoids Sales by Country (2020-2025)
10.1.3 South America Oral Retinoids Sales Forecast by Country (2026-2031)
10.2 South America Oral Retinoids Market Size by Country
10.2.1 South America Oral Retinoids Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
10.2.2 South America Oral Retinoids Market Size by Country (2020-2025)
10.2.3 South America Oral Retinoids Market Size Forecast by Country (2026-2031)
11 Middle East and Africa by Country
11.1 Middle East and Africa Oral Retinoids Sales by Country
11.1.1 Middle East and Africa Oral Retinoids Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
11.1.2 Middle East and Africa Oral Retinoids Sales by Country (2020-2025)
11.1.3 Middle East and Africa Oral Retinoids Sales Forecast by Country (2026-2031)
11.2 Middle East and Africa Oral Retinoids Market Size by Country
11.2.1 Middle East and Africa Oral Retinoids Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
11.2.2 Middle East and Africa Oral Retinoids Market Size by Country (2020-2025)
11.2.3 Middle East and Africa Oral Retinoids Market Size Forecast by Country (2026-2031)
12 Value Chain and Sales Channels Analysis
12.1 Oral Retinoids Value Chain Analysis
12.1.1 Oral Retinoids Key Raw Materials
12.1.2 Key Raw Materials Price
12.1.3 Raw Materials Key Suppliers
12.1.4 Manufacturing Cost Structure
12.1.5 Oral Retinoids Production Mode & Process
12.2 Oral Retinoids Sales Channels Analysis
12.2.1 Direct Comparison with Distribution Share
12.2.2 Oral Retinoids Distributors
12.2.3 Oral Retinoids Customers
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.